Skip to main content
Home
  • About Us
    • About Us
    • Mission & Values
    • Leadership
    • News
    • Careers
    • Partnerships
    • Support
    • Achievements
  • For Researchers
    • Clinical Trials
      • Allergy & Asthma
      • Autoimmune Disease
      • Transplantation
      • Type 1 Diabetes
    • Core Facilities
    • Lab Protocols
      • ITN Protocols
      • T1D Preclinical Consortium
    • Policies
      • Publications Policy
    • Proposals
      • Submit Proposal
      • Current RFPs
      • Past RFPs
    • Publications
    • TrialShare
    • Strategic Plans
      • Allergy
      • Autoimmune Disease
        • Type 1 Diabetes
      • Transplantation
  • For Patients
    • Allergy & Asthma
    • Autoimmune Disease
    • Transplantation
      • Kidney
      • Liver
    • Type 1 Diabetes
    • Clinical Trial Info
  • TrialShare
  • Contact
    • Contact Us
      • BRI - Seattle Office
      • UCSF - San Francisco Office
    • Media Inquiries
Home

Secondary links

  • Home
  • TrialShare
  • Member Portal
  • About Us
    • About Us
    • Mission & Values
    • Leadership
    • News
    • Careers
    • Partnerships
    • Support
    • Achievements
  • For Researchers
    • Clinical Trials
    • Core Facilities
    • Lab Protocols
    • Policies
    • Proposals
    • Publications
    • TrialShare
    • Strategic Plans
  • For Patients
    • Allergy & Asthma
    • Autoimmune Disease
    • Transplantation
    • Type 1 Diabetes
    • Clinical Trial Info
  • TrialShare
  • Contact
    • Contact Us
    • Media Inquiries

Primary links

  • About Us
  • Mission & Values
  • Leadership
  • News
  • Careers
  • Partnerships
  • Support
  • Achievements

The ITN at the American Transplant Congress

June 01, 2009 --

Three abstracts from Immune Tolerance Network (ITN) studies are being presented at this year's American Transplant Congress in Boston, MA, held May 20-June 3, 2009.

UCSF's Sandy Feng will present the preliminary results of her study of immunosuppression withdrawal in pediatric liver transplant recipients. The three center study is fully enrolled, with 20 subjects aged 5-15 years. 

Ken Newell, from Emory University and the ITN's Vicki Seyfert-Margolis will also present their findings from the ITN Registry of Tolerant Kidney Transplant Recipients, in which they have found a strong association of B cells with tolerance in renal transplantation.

Similarly, Robert Lechler and Maria Hernandez-Fuentes from Imperial College London, will present the results of their European efforts to study tolerant kidney transplant recipients, in which they present their evidence for B cell and NK cell biomarkers of tolerance. 

See the attachment below for abstracts and times/locations.

More Information

2009.ATCAbstracts.pdf346.09 KB

The Immune Tolerance Network and is sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

National Institute of Allergy and Infectious Diseases

Footer

  • Home
  • Sponsors
  • Careers
  • Contact
  • Search

© 2021 Immune Tolerance Network

  • Privacy
  • Terms of Use
  • Accessibility